Literature DB >> 2905086

In vivo suppression of stearyl CoA desaturase activity by griseofulvin: evidence against the involvement of lipid peroxidation.

M T Williams1, L Simonet.   

Abstract

Administration of a diet containing 2.5% (w/w) griseofulvin (GF) resulted in a significant decrease in hepatic microsomal stearyl CoA desaturase activity compared to desaturase activity in microsomes from animals fed a normal rat chow diet. Desaturase activities were 0.66 +/- 0.18 vs 0.16 +/- 0.09 nmoles oleyl CoA formed/min/mg protein for control and GF-fed animals, respectively. Examination of lipid peroxides in microsomes from control and GF-treated rats showed an approximate fivefold higher concentration of lipid peroxides in microsomes from GF-treated rats compared to that from controls. However, when rats were fed a diet containing GF and diphenyl-p-phenylenediamine an inhibitor of lipid peroxidation, stearyl CoA desaturase activity was still similar to that observed with GF alone, even though microsomal lipid peroxides were reduced to nondetectable levels. In vitro stimulation of microsomal lipid peroxidation using ADP-Fe and EDTA-Fe did not result in a significant decrease in desaturase activity. Results of our experiments show that dietary administration of GF results in a marked decrease in stearyl CoA desaturase activity in hepatic microsomes. Although GF feeding stimulates microsomal lipid peroxidation, increase in microsomal peroxidation does not appear to be the mechanism by which GF feeding decreases desaturase activity. GF appears to act by decreasing the terminal desaturase activity.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2905086     DOI: 10.1016/0041-008x(88)90013-0

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

1.  Sex-related differences in the enhancing effects of perfluoro-octanoic acid on stearoyl-CoA desaturase and its influence on the acyl composition of phospholipid in rat liver. Comparison with clofibric acid and tiadenol.

Authors:  Y Kawashima; N Uy-Yu; H Kozuka
Journal:  Biochem J       Date:  1989-11-01       Impact factor: 3.857

2.  Human colon tumor cell line LS174T drug metabolizing system.

Authors:  D K Hammond; H W Strobel
Journal:  Mol Cell Biochem       Date:  1990-03-27       Impact factor: 3.396

3.  Are reduction potentials of antifungal agents relevant to activity?

Authors:  P Kovacic; P F Kiser; B A Feinberg
Journal:  Pharm Res       Date:  1990-03       Impact factor: 4.200

4.  Autism spectrum disorders.

Authors:  Kara Fitzgerald; Mark Hyman; Kathie Swift
Journal:  Glob Adv Health Med       Date:  2012-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.